Multiple mutations conferring ciprofloxacin resistance in Staphylococcus aureus demonstrate long-term stability in an antibiotic-free environment

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 3, 2000, Pages 353-356

  Jones, Mark E ^a,c   Boenink, Nienke M ^a   Verhoef, Jan ^a   Köhrer, Karl ^b   Schmitz, Franz Josef ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c MRL Pharmaceutical Services   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; QUINOLONE;

ANTIBIOTIC RESISTANCE; ARTICLE; GENE MUTATION; GENETIC STABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROMOTER REGION; STAPHYLOCOCCUS AUREUS;

STAPHYLOCOCCUS AUREUS;

EID: 0034009925     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.3.353     Document Type: Article

References (12)

1. Kristinsson, K. G. (1997). Effect of antimicrobial use and others risk factors on antimicrobial resistance in pneumococci. Microbial Drug Resistance 3, 117-23.
2. Seppälä, H., Klaukka, T., Vuopio-Varkila, J., Muotiala, A., Helenius, H., Lager, K. et al. (1997). The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance amongst group A streptococci in Finland. New England Journal of Medicine 337, 441-6.
3. Bouma, J. E. & Lenski, R. E. (1988). Evolution of a bacteria/ plasmid association. Nature 335, 351-2.
4. Schrag S. J. & Perrot, V. (1996). Reducing antibiotic resistance. Nature 381, 120-1.
5. Ito, H., Yoshida, H., Bogaki-Shonnai, M., Niga, T., Hattori, H. & Nakamura, S. (1994). Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 38, 2014-23.
6. Yamagishi, J., Kojima, T., Oyamada, Y., Fujimoto, K., Hattori, H., Nakumara, S. et al. (1996). Alterations in the DNA topoisomerase IV grIA gene responsible for quinolone resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 40, 1157-63.
7. Yoshida, H., Bogaki, M., Nakamura, S., Ubukata, K., & Konno, M. (1990). Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. Journal of Bacteriology 172, 6942-9.
8. Aleixandre, V., Urios, A., Herrera, G. & Blanco, M. (1989). New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling. Molecular and General Genetics 219, 306-12.
9. National Committee for Clinical Laboratory Standards. (1998). Performance Standards for Antimicrobial Susceptibility Testing-Eighth Informational Supplement: Approved Standard M100-S8. NCCLS, Wayne, PA.
10. Lenski, R. E., Rose, M. R., Simpson, S. C. & Tadler, S. C. (1991). Long-term experimental evolution in Escherichia coli. I. Adaptation and divergence during 2,000 generations. American Nature 138, 1315-41.
11. Schmitz, F.-J., Jones, M. E., Hofmann, B., Hansen, B., Scheuring, S., Luckefahr, M. et al. (1998). Characterization of grIA, grIB, gyrA and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC. Antimicrobial Agents and Chemotherapy 42, 1249-52.
12. Schmitz, F.-J., Hofmann, B., Hansen B., Scheuring, S., Verhoef, J., Fluit, A. et al. (1999). Stability of grIA, grIB, gyrA and gyrB mutations and corresponding MIC-values of fluoroquinolones in different clonal populations of methicillin-resistant Staphylococcus aureus. Clinical Microbiology and Infection 5, 287-90.